Application of ellagic acid metabolite urolithin A in the preparation of anti-enteroviral drugs
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZUNYI MEDICAL UNIVERSITY
- Publication Date
- 2021-08-03
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The technical field of pharmaceutical preparations of the present invention particularly relates to the application of ellagic acid metabolite Urolithin A in the preparation of anti-enterovirus drugs. Background technique
[0002] Hand, foot, and mouth disease (HFMD) is a common infectious disease in children worldwide caused by human enterovirus (HEV), with a high incidence in children under 5 years old. HFMD is mostly a self-limiting disease, accompanied by symptoms such as fever, rash on hands and feet, and oral herpes. However, in some patients, the disease progresses rapidly, which can lead to severe pulmonary edema, neurological and systemic complications, and even death. Enterovirus 71 (human enterovirus 71, EV71), a member of HEV, is a single-stranded positive-sense RNA virus belonging to the family Picornaviridae, and is the main pathogen that causes severe and fatal cases of HFMD. Since 1997, HFMD has broken out in the Asia-Pacific region. ...